This NDC is on FDA's drug shortage list (posted Sep 20, 2023)

Product Information

LISDEXAMFETAMINE 60 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $2.6051 per EA under NDC 00527466637. Its NADAC has been published 162 times since Oct 11, 2023.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 60 MG CAPSULE

Lisdexamfetamine Dimesylate
$2.6051per EA
DEA Schedule CII

Strength

60 mg/1

NDC

00527466637

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215802

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has been published 162 times since Oct 11, 2023, and over the history we have for it it has declined 23.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6051 per EA
All-time high$6.7212 (Apr 10, 2024)
All-time low$2.6051 (Oct 21, 2026)
52-week high$3.2668
52-week low$2.6051
Median price$3.9099
Average price$4.1426
Largest weekly change-49.8% (Apr 17, 2024)
Weeks tracked162
Tracking sinceOct 11, 2023

Price History

1W

0.0%

1M

-2.5%

3M

-9.1%

6M

-12.3%

1Y

-22.2%

3Y

-42.2%

5Y

N/A

All

-23.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 60 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 60 MG CAPSULE, manufactured by Lannett Company Inc., is $2.6051 per EA (NDC 00527466637), effective Nov 11, 2026.

How has the price of LISDEXAMFETAMINE 60 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has declined 23.2%. It has been tracked across 162 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 60 MG CAPSULE?

Since Oct 11, 2023, the NADAC for LISDEXAMFETAMINE 60 MG CAPSULE has ranged from a low of $2.6051 (Oct 21, 2026) to a high of $6.7212 (Apr 10, 2024), with a median of $3.9099 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 60 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 60 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 60 MG CAPSULE?

LISDEXAMFETAMINE 60 MG CAPSULE (NDC 00527466637) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 60 MG CAPSULE in shortage?

Yes — NDC 00527466637 is currently listed in FDA's drug shortage database (posted Sep 20, 2023).